Novacyt Share News (NCYT)

Novacyt Information

Buy NCYT Shares
Add NCYT to Watchlist
Add NCYT to Alert

Share Price Information for Novacyt (NCYT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 64.40

Bid: 38.00

Ask: 0.00

Change: 0.00 (0.00%)

Spread: 26.40 (69.474%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 64.40

Last checked at -

Novacyt Trading Positively, In Funding Talks With Lenders

Wed, 27th Feb 2019 11:08

LONDON (Alliance News) - Novacyt SA, said Tuesday that 2019 trading has started positively and is in line with management expectations.

The clinical diagnostics company also said that it remains in talks for the sale of NOVAprep and the Clinical Lab businesses. It is separately in also in talks with debt providers for a material investment of which a significant proportion will be used to consolidate debt obligations.

Novacyt expects to complete the financing within the next six to eight weeks. As at February 22, the company had EUR950,000 in funds, ahead of its expectations.

Shares in the company were trading 9.9% lower at EUR0.26 on Tuesday afternoon.

More News

6 Feb 2024 12:48

Novacyt confirms end of Yourgene Taiwan disposal discussions

(Sharecast News) - Novacyt announced on Tuesday that it had received formal notification from INEX Innovate terminating discussions around the acquisition of Yourgene Health Taiwan.

2 Jan 2024 08:12

Novacyt taps Steve Gibson for CFO

(Sharecast News) - Biotechnology group Novacyt has appointed Steve Gibson to the role of chief financial officer with immediate effect.

21 Dec 2023 15:49

Novacyt facing delays in disposal of Yourgene Taiwan

(Sharecast News) - Molecular diagnostics company Novacyt updated the market on the conditional disposal of its laboratory in Taiwan, which it acquired as part of its purchase of Yourgene Health on 8 September.

3 Jul 2023 09:07

Novacyt to buy Yourgene Health in £16.7m deal

(Sharecast News) - Yourgene Health surged on Monday after it agreed to be bought by Novacyt in a £16.7m deal.

6 Dec 2022 12:29

UK regulator approves Novacyt Covid-19 test

(Sharecast News) - Shares in clinical diagnostics specialist Novacyt sparked on Tuesday, after the UK regulator approved its latest Covid-19 test.

15 Jul 2022 08:43

Novacyt's exsig receives UK approval

(Sharecast News) - Clinical diagnostics group Novacyt's exsig Covid-19 Direct Real-Time PCR test has received approval from the UK's Health Security Agency.

17 Feb 2022 15:38

Novacyt gets another Covid-19 test approved in the UK

(Sharecast News) - Clinical diagnostics company Novacyt announced on Thursday that its 'PROmate' Covid-19 2G Real-Time PCR test had been approved in the UK, under the UK Health Security Agency's coronavirus test device approvals (CTDA) regulations.

26 Nov 2021 08:02

Novacyt gets UK approval for 'genesig' Covid-19 test

(Sharecast News) - Clinical diagnostics specialist Novacyt announced on Friday thatots 'genesig' Covid-19 real-time PCR test has been approved in the UK.

2 Nov 2021 11:45

Novacyt flags possible £3m hit from Covid test regulations change

(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on the availability of its Covid-19 tests in the UK on Tuesday, following the implementation of amendments to the UK Health Security Agency's coronavirus test device regulations, or 'CTDA'.

30 Sep 2021 09:37

Novacyt launches new 'Winterplex' test, lateral flow tests delayed

(Sharecast News) - Clinical diagnostics specialist Novacyt issued a research and development update on Thursday, including the launch of a new CE-marked 'Winterplex' polymerase chain reaction (PCR) test to diagnose Covid-19, respiratory syncytial virus (RSV) and types of influenza.

27 Sep 2021 08:15

Novacyt swings to first-half loss amid DHSC dispute

(Sharecast News) - Clinical diagnostics specialist Novacyt reported group consolidated unaudited revenue of £54m in its first half on Monday, down from £63.3m year-on-year, which excluded £40.8m of Department of Health and Social Care (DHSC) revenues, while that contract dispute continued.

16 Sep 2021 11:05

Novacyt FY revenues potentially 'materially affected' by outcome of DHSC dispute

(Sharecast News) - Biotechnology company Novacyt warned on first-half revenues on Thursday as a result of its ongoing dispute with the US Department of Health and Social Care.

18 Aug 2021 10:12

First half revenues up more than 50pc for Novacyt

(Sharecast News) - Novacyt said in an update on Wednesday that unaudited revenue in its first half was ahead more than 50% year-on-year, at £94.7m.

29 Jul 2021 15:31

Novacyt appoints David Allmond as new chief executive

(Sharecast News) - Clinical diagnostics specialist Novacyt announced the appointment of David Allmond as its new chief executive officer and a member of its board on Thursday, effective from 18 October.

29 Jun 2021 09:03

Novacyt launches two new rapid Covid-19 test products

(Sharecast News) - Clinical diagnostics specialist Novacyt announced the planned launch of two 'PathFlow' Covid-19 antigen lateral flow tests on Tuesday, to strengthen its Covid-19 portfolio and to pursue significant new market opportunities, particularly in point-of-care settings.

Latest Share Chat

Novacyt Share News (NCYT)

Share Price Information for Novacyt (NCYT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Novacyt Trading Positively, In Funding Talks With Lenders

Login to your account

Quickpicks are a member only feature

Login to your account